Search research articles
Contact Us
Filters
Showing results (151-160 of 168) with videos related to
Page
of 17
Sort By:
Journal of Medicinal Chemistry
|
August 3, 2007
Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists Part 1. The discovery of arylacetamides as viable replacements for the dihydropyrimidinone moiety of an HTS hit
Yu Jiang, Chien-An Chen, Kai Lu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 23, 2008
The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity
Mary W Walker, Toni D Wolinsky, Vrej Jubian, et al.
Journal of Medicinal Chemistry
|
August 3, 2007
Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key fragments of HTS hits
Chien-An Chen, Yu Jiang, Kai Lu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 24, 2007
Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis
D J David, K C Klemenhagen, K A Holick, et al.
Pharmaceutics
|
November 11, 2022
Ileocolonic-Targeted JAK Inhibitor: A Safer and More Effective Treatment for Inflammatory Bowel Disease
Vipul Yadav, Aileen House, Silvia Matiz, et al.
Journal of Medicinal Chemistry
|
July 14, 2025
Discovery of ZN-c5, an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) with Improved Pharmacokinetics
Sayee G Hegde, Peter Q Huang, Kevin D Bunker, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 29, 2021
Characterization of the Onset, Progression, and Reversibility of Morphological Changes in Mouse Lung after Pharmacological Inhibition of Leucine-Rich Kinase 2 Kinase Activity
Dianne K Bryce, Chris M Ware, Janice D Woodhouse, et al.
Pediatric Blood & Cancer
|
January 20, 2025
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors
Aaron B Ross, Kriti Puri, Thomas L Johnson, et al.
Physical Review Letters
|
October 22, 2021
Magnetic Field Induced Quantum Spin Liquid in the Two Coupled Trillium Lattices of K_{2}Ni_{2}(SO_{4})_{3}
Ivica Živković, Virgile Favre, Catalina Salazar Mejia, et al.
Cells
|
May 13, 2026
uPAR-Targeting Cytotoxic Antibody-Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells for Autoimmune Indications
Handan Xiang, Grace Pham Mortenson, Simon B Lang, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 168) with videos related to
Sort By:
Page
of 17
Journal of Medicinal Chemistry
|
August 3, 2007
Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists Part 1. The discovery of arylacetamides as viable replacements for the dihydropyrimidinone moiety of an HTS hit
Yu Jiang, Chien-An Chen, Kai Lu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 23, 2008
The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity
Mary W Walker, Toni D Wolinsky, Vrej Jubian, et al.
Journal of Medicinal Chemistry
|
August 3, 2007
Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key fragments of HTS hits
Chien-An Chen, Yu Jiang, Kai Lu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 24, 2007
Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis
D J David, K C Klemenhagen, K A Holick, et al.
Pharmaceutics
|
November 11, 2022
Ileocolonic-Targeted JAK Inhibitor: A Safer and More Effective Treatment for Inflammatory Bowel Disease
Vipul Yadav, Aileen House, Silvia Matiz, et al.
Journal of Medicinal Chemistry
|
July 14, 2025
Discovery of ZN-c5, an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) with Improved Pharmacokinetics
Sayee G Hegde, Peter Q Huang, Kevin D Bunker, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 29, 2021
Characterization of the Onset, Progression, and Reversibility of Morphological Changes in Mouse Lung after Pharmacological Inhibition of Leucine-Rich Kinase 2 Kinase Activity
Dianne K Bryce, Chris M Ware, Janice D Woodhouse, et al.
Pediatric Blood & Cancer
|
January 20, 2025
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors
Aaron B Ross, Kriti Puri, Thomas L Johnson, et al.
Physical Review Letters
|
October 22, 2021
Magnetic Field Induced Quantum Spin Liquid in the Two Coupled Trillium Lattices of K_{2}Ni_{2}(SO_{4})_{3}
Ivica Živković, Virgile Favre, Catalina Salazar Mejia, et al.
Cells
|
May 13, 2026
uPAR-Targeting Cytotoxic Antibody-Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells for Autoimmune Indications
Handan Xiang, Grace Pham Mortenson, Simon B Lang, et al.
Page
of 17